NCT05149729

Brief Summary

Comparison of preoperative and postoperative mid-term course of patients with Crowe Type 3 and Type 4 hip dysplasia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 8, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2024

Completed
Last Updated

December 8, 2021

Status Verified

December 1, 2021

Enrollment Period

3.2 years

First QC Date

October 8, 2021

Last Update Submit

December 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    The WOMAC score range, which indicates the clinical satisfaction of the patients, is between 0-100.

    The degree of improvement in Vomac score will be evaluated by looking at preoperative and postoperative 12th month Vomac scores.( 0-12th month )

Study Arms (1)

Crowe type 3 and 4 patients undergoing shortened hip replacement

EXPERIMENTAL

Clinical and radiological results of Crowe type 3 and 4 patients who underwent shortened hip prosthesis at 12 and 24 months

Procedure: Shortened hip arthroplasty

Interventions

Crowe type 3 and 4 patients who underwent shortened hip prosthesis

Crowe type 3 and 4 patients undergoing shortened hip replacement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Crowe type 3 and 4 patients over 18 years of age who had shortened hip replacement surgery

You may not qualify if:

  • Crowe type 1 or 2 patients over 18 years of age who had shortened hip replacement surgery
  • Patients who have previously operated on the contralateral hip
  • Patients who underwent shortened hip replacement for a reason other than developmental dysplasia of the hip

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakıf University

Istanbul, Fatih, 34500, Turkey (Türkiye)

RECRUITING

Related Links

MeSH Terms

Conditions

Hip Dislocation

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesHip Injuries

Study Officials

  • Gökçer Uzer

    Bezmialem Vakif University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Patients over the age of 18 who underwent Crowe Type 3 and Type 4 shortened hip prosthesis
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopaedic surgeon

Study Record Dates

First Submitted

October 8, 2021

First Posted

December 8, 2021

Study Start

February 10, 2021

Primary Completion

May 10, 2024

Study Completion

June 10, 2024

Last Updated

December 8, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations